[[(2S,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷酸
• 英文名称: [[(2S,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
• 化学式: C₉H₁₆N₃O₁₄P₃
• 分子量: 483.16
• InChiKey: PCDQPRRSZKQHHS-ZAKLUEHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -5.6
• 重原子数：
  29
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  268
• 氢给体数：
  7
• 氢受体数：
  14

文献信息

• [EN] CATIONIC LIPIDS AND USES THEREOF<br/>[FR] LIPIDES CATIONIQUES ET LEURS UTILISATIONS
  申请人：FACTOR BIOSCIENCE INC

  公开号：WO2021003462A1

  公开（公告）日：2021-01-07

  The present invention relates to novel cationic lipids of formula I, and more specifically formula IV. These are used, for example, in liposomes for the delivery of nucleic acids to cells.

  本发明涉及新型公式I的阳离子脂质，更具体地是公式IV。例如，这些脂质可用于脂质体中将核酸传递给细胞。
• BASE-MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN
  申请人：Hoerr Ingmar

  公开号：US20100047261A1

  公开（公告）日：2010-02-25

  The present application describes a base-modified RNA and the use thereof for increasing the expression of a protein and for the preparation of a pharmaceutical composition, especially a vaccine, for the treatment of tumours and cancer diseases, heart and circulatory diseases, infectious diseases, autoimmune diseases or monogenetic diseases, for example in gene therapy. The present invention further describes an in vitro transcription method, in vitro methods for increasing the expression of a protein using the base-modified RNA, and an in vivo method.

  本申请描述了一种基础修饰的RNA及其用于增加蛋白质表达和制备药物组合物的用途，特别是用于治疗肿瘤和癌症、心脏和循环系统疾病、传染病、自身免疫性疾病或单基因遗传病，例如基因治疗。本发明还描述了一种体外转录方法、使用基础修饰RNA增加蛋白质表达的体外方法以及一种体内方法。
• 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS
  申请人：Anilkumar Gopinadhan N.

  公开号：US20100239527A1

  公开（公告）日：2010-09-23

  The present invention relates to 2,3-Substituted Azaindole Derivatives, compositions comprising at least one 2,3 -Substituted Azaindole Derivatives, and methods of using the 2,3-Substituted Azaindole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

  本发明涉及2,3-取代的氮杂吲哚衍生物，包括至少一种2,3-取代的氮杂吲哚衍生物的组合物，以及使用2,3-取代的氮杂吲哚衍生物治疗或预防患者的病毒感染或与病毒有关的疾病的方法。
• TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS
  申请人：Bennett Frank

  公开号：US20110104109A1

  公开（公告）日：2011-05-05

  The present invention relates to Tetracyclic Indole Derivatives, compositions comprising at least one Tetracyclic Indole Derivative, and methods of using the Tetracyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

  本发明涉及四环吲哚衍生物，包括至少一种四环吲哚衍生物的组合物，以及使用四环吲哚衍生物治疗或预防患者病毒感染或与病毒相关的疾病的方法。
• GLYCOSYLTRANSFERASE REVERSIBILITY FOR SUGAR NUCLEOTIDE SYNTHESIS AND MICROSCALE SCANNING
  申请人：Thorson Jon S.

  公开号：US20130004979A1

  公开（公告）日：2013-01-03

  The present invention generally relates to materials and methods for exploiting glycosyltransferase reversibility for nucleotide diphosphate (NDP) sugar synthesis. The present invention provides engineered glycosyltransferase enzymes characterized by improved reaction reversibility and expanded sugar donor specificity as compared to corresponding non-mutated glycosyltransferase enzymes. Such reagents provide advantageous routes to NDP sugars for subsequent use in a variety of biomedical applications, including enzymatic and chemo-enzymatic glycorandomization.

  本发明一般涉及利用糖基转移酶可逆性合成核苷酸二磷酸（NDP）糖的材料和方法。本发明提供了改良反应可逆性并扩展糖供体特异性的工程糖基转移酶酶，与相应的非突变糖基转移酶酶相比，具有更好的反应可逆性和扩展的糖供体特异性。这些试剂提供了有利的NDP糖路线，用于随后在各种生物医学应用中使用，包括酶促和化学酶促糖随机化。